# OnCo record nct07601048 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07601048/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07601048", "NCT07601048" ;
  schema:name "A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment"@en ;
  schema:description "A phase 3 trial of Fulzerasib, Garsorasib and Glecirasib in Non-small-cell lung cancer, run by Shandong Suncadia Medicine Co., Ltd., not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07601048/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07601048> ;
  onco:status "planned" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:drugs <https://onco.cc/drugs/fulzerasib/>, <https://onco.cc/drugs/garsorasib/>, <https://onco.cc/drugs/glecirasib/> ;
  onco:companies <https://onco.cc/companies/hengrui/> .